P&K Skin Research Center Co. Ltd (347740) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.021x

Based on the latest financial reports, P&K Skin Research Center Co. Ltd (347740) has a cash flow conversion efficiency ratio of 0.021x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩1.70 Billion ≈ $1.15 Million USD) by net assets (₩81.39 Billion ≈ $55.16 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See P&K Skin Research Center Co. Ltd defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.

P&K Skin Research Center Co. Ltd - Cash Flow Conversion Efficiency Trend (2018–2024)

This chart illustrates how P&K Skin Research Center Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

P&K Skin Research Center Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of P&K Skin Research Center Co. Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Airtime Partecipazioni SpA
PA:ALMEX
0.316x
CTK Co. Ltd
KQ:260930
-0.017x
Yuanta Securities Korea Co Ltd Preference Shares
KO:003475
-0.033x
REDCO PRP GROUP LTD -05
F:8KI
N/A
Kirklands Inc
NASDAQ:KIRK
0.190x
Dabomb Protein
TWO:6578
0.000x
Farm Price Holdings Berhad
KLSE:0304
0.039x
Lii Hen Industries Bhd
KLSE:7089
0.033x

Annual Cash Flow Conversion Efficiency for P&K Skin Research Center Co. Ltd (2018–2024)

The table below shows the annual cash flow conversion efficiency of P&K Skin Research Center Co. Ltd from 2018 to 2024. For the full company profile with market capitalisation and key ratios, see 347740 market cap.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 ₩76.94 Billion
≈ $52.14 Million
₩9.03 Billion
≈ $6.12 Million
0.117x +57.07%
2023-12-31 ₩74.24 Billion
≈ $50.31 Million
₩5.55 Billion
≈ $3.76 Million
0.075x -29.50%
2022-12-31 ₩70.81 Billion
≈ $47.98 Million
₩7.51 Billion
≈ $5.09 Million
0.106x -13.13%
2021-12-31 ₩63.07 Billion
≈ $42.74 Million
₩7.70 Billion
≈ $5.22 Million
0.122x -21.66%
2020-12-31 ₩55.63 Billion
≈ $37.70 Million
₩8.67 Billion
≈ $5.87 Million
0.156x -41.24%
2019-12-31 ₩24.50 Billion
≈ $16.60 Million
₩6.49 Billion
≈ $4.40 Million
0.265x -0.76%
2018-12-31 ₩15.96 Billion
≈ $10.81 Million
₩4.26 Billion
≈ $2.89 Million
0.267x --

About P&K Skin Research Center Co. Ltd

KQ:347740 Korea Diagnostics & Research
Market Cap
$37.29 Million
₩55.02 Billion KRW
Market Cap Rank
#23028 Global
#1522 in Korea
Share Price
₩1905.00
Change (1 day)
-0.68%
52-Week Range
₩1810.00 - ₩3235.00
All Time High
₩7272.32
About

P&K Skin Research Center Co., Ltd. engages in the evaluation and research of dermatological products in South Korea. It provides scientific information and technical support services for new cosmetic raw material development, functional cosmetics, and human application testing of quasi-drugs. The company performs human application, safety, efficacy, cosmeceuticals, health food, sensory, and in vi… Read more